Applovin (APP) and CVC (CVC NA) are reportedly considering bids for Essity's (ESSITYB SS) EUR 3bln tissue unit, Bloomberg reports

Carve-out processes of this kind, a large-cap consumer or industrial group shedding a non-core division with a stated price tag attached, tend to follow a familiar sequence: an initial leak naming interested parties, a first round of non-binding bids, and then a narrowing to a final round where financing certainty and synergies decide the winner. The notable feature here is the mixed bidder profile, a financial sponsor alongside what reads as a strategic or at least less conventional buyer, and precedent in such auctions is that sponsors anchor valuation discipline while strategics justify premiums through synergies, with the gap between the two often defining how competitive the process gets. Attaching a specific headline valuation at the leak stage is itself a signal: sellers or their advisers frequently float a number early to anchor expectations and test appetite, and final pricing in comparable processes has tended to settle relative to that anchor depending on bid depth. For the seller's equity, past episodes of this kind have seen the shares trade on execution risk around the headline figure, with upside on a competitive auction and downside if the process is pulled or delayed. The worth-watching items are confirmation of formal bids, any additional names entering the process, and whether the seller frames the disposal alongside a capital return or deleveraging message, which historically shapes how the proceeds are received.